The science is there - life expectancy indications, proof of blood/brain barrier overcome, autophagy in action, and statistical comparison to Proact database. I'm very happy for them to focus on the one egg! The Phase 2 will simply shore up what we already know MPL can achieve, but it will have that all important factor of a larger patient group and compared against the standard of care instead of stats. Bring on the interim readout next year and offers to buy from $3!
Ann: Investor Briefings & Webinar Notice, page-39
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $80.22M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.0¢ | 16.5¢ | $210.6K | 1.236M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 274938 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 15000 | 2 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |